CNDP2 inhibitors represent a class of chemical compounds that have garnered significant attention in the field of biochemistry and molecular biology due to their ability to modulate the activity of CNDP2, or Cytosolic Non-specific Dipeptidase 2. CNDP2 is an enzyme that plays a crucial role in the hydrolysis of dipeptides, which are short chains of two amino acids linked together. These dipeptides are involved in various cellular processes, including protein degradation and amino acid homeostasis. CNDP2 inhibitors, as the name suggests, are characterized by their capacity to hinder or suppress the enzymatic activity of CNDP2, thereby altering the dynamics of dipeptide metabolism within cells.
One of the key mechanisms of action employed by CNDP2 inhibitors involves competitive inhibition. These inhibitors typically have structural similarities to the natural substrates of CNDP2, enabling them to bind to the enzyme's active site. By occupying this active site, CNDP2 inhibitors prevent the binding of dipeptide substrates to the enzyme. This competitive binding effectively obstructs the enzymatic hydrolysis of dipeptides, resulting in the accumulation of these molecules within the cellular environment. This disruption in dipeptide metabolism can have far-reaching consequences, impacting various cellular processes dependent on dipeptides. Additionally, some CNDP2 inhibitors may function as reversible inhibitors, allowing for the transient modulation of CNDP2 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid inhibits CNDP2 through modulation of enzymatic activity, possibly by binding to the active site or altering the enzyme's conformation. It may also affect CNDP2 expression. | ||||||
Bestatin | 58970-76-6 | sc-202975 | 10 mg | $128.00 | 19 | |
Bestatin is a competitive inhibitor of CNDP2, binding to the enzyme's active site and blocking substrate binding. | ||||||
Captopril | 62571-86-2 | sc-200566 sc-200566A | 1 g 5 g | $48.00 $89.00 | 21 | |
Captopril is an ACE inhibitor that can indirectly inhibit CNDP2 by reducing angiotensin II levels, which regulate CNDP2 expression. | ||||||
Diprotin A | 90614-48-5 | sc-497890 | 5 mg | $286.00 | ||
Diprotin A is a tripeptide inhibitor that competes with dipeptide substrates for binding to CNDP2, effectively blocking its activity. | ||||||
Cilastatin | 82009-34-5 | sc-207434 | 10 mg | $190.00 | ||
Cilastatin is a renal dipeptidase inhibitor, potentially inhibiting CNDP2 in the kidney by preventing the breakdown of dipeptides. | ||||||
L-2,4-Diaminobutyric Acid, Dihydrochloride | 1883-09-6 | sc-218625 | 1 g | $106.00 | ||
L-2,4-diaminobutyric acid is a substrate analog that competitively inhibits CNDP2 by binding to the enzyme's active site. | ||||||
Imidapril hydrochloride | 89371-37-9 | sc-207751 | 10 mg | $105.00 | ||
Imidapril, an ACE inhibitor, indirectly influences CNDP2 activity by regulating angiotensin II levels, which can affect its expression. | ||||||